News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
460,625 Results
Type
Article (51078)
Company Profile (100)
Press Release (409447)
Section
Business (129292)
Career Advice (1493)
Deals (18786)
Drug Delivery (65)
Drug Development (60927)
Employer Resources (101)
FDA (9624)
Job Trends (10273)
News (218374)
Policy (17803)
Tag
2024 BioCapital Digital (3)
2024 BioForest Digital (2)
2024 BioForest Standard (1)
2024 BioMidwest Standard (1)
2024 Bio NC Digital (7)
2024 Bio NC Standard (1)
2024 Biotech Bay Standard (5)
2024 Biotech Beach Digital (3)
2024 Biotech Beach Standard (3)
2024 Genetown Standard (3)
2024 Lone Star Bio Digital (5)
2024 Pharm Country Digital (1)
2024 Pharm Country Standard (3)
2025 Lone Star Bio Digital (2)
2026 BioMidwest Elite (1)
2026 Biotech Beach Elite (1)
2026 Genetown Elite (1)
2026 Pharm Country Premier (1)
2026 Pharm Country Standard (1)
Academia (2688)
Academic (1)
Accelerated approval (1)
Adcomms (11)
Allergies (54)
Alliances (36906)
ALS (70)
Alzheimer's disease (1243)
Antibody-drug conjugate (ADC) (82)
Approvals (9652)
Artificial intelligence (161)
Autoimmune disease (10)
Automation (8)
Bankruptcy (128)
Best Places to Work (8296)
BIOSECURE Act (11)
Biosimilars (47)
Biotechnology (68)
Bladder cancer (35)
Brain cancer (19)
Breast cancer (189)
Cancer (1475)
Cardiovascular disease (95)
Career advice (1231)
Career pathing (23)
CAR-T (128)
Cell therapy (327)
Cervical cancer (8)
Clinical research (47916)
Collaboration (616)
Compensation (115)
Complete response letters (9)
COVID-19 (2192)
CRISPR (28)
C-suite (136)
Cystic fibrosis (89)
Data (1439)
Decentralized trials (2)
Denatured (10)
Depression (27)
Diabetes (155)
Diagnostics (4508)
Digital health (12)
Diversity (4)
Diversity, equity & inclusion (26)
Drug discovery (89)
Drug pricing (59)
Drug shortages (11)
Duchenne muscular dystrophy (39)
Earnings (45657)
Editorial (20)
Employer branding (15)
Employer resources (89)
Events (59873)
Executive appointments (452)
FDA (10324)
Featured Employer (31)
Fibrodysplasia Ossificans Progressiva (1)
Friedreich's ataxia (3)
Frontotemporal dementia (4)
Funding (498)
Gene editing (65)
Generative AI (17)
Gene therapy (190)
GLP-1 (467)
Government (2782)
Grass and pollen (2)
Guidances (32)
Healthcare (12893)
Huntington's disease (10)
IgA nephropathy (10)
Immunology and inflammation (64)
Indications (20)
Infectious disease (2276)
Inflammatory bowel disease (103)
Inflation Reduction Act (5)
Influenza (37)
Intellectual property (59)
Interviews (285)
IPO (8912)
IRA (31)
Job creations (2328)
Job search strategy (1063)
Kidney cancer (7)
Labor market (18)
Layoffs (291)
Leadership (8)
Legal (3124)
Liver cancer (42)
Lung cancer (207)
Lymphoma (95)
Machine learning (2)
Management (33)
Manufacturing (178)
MASH (45)
Medical device (7330)
Medtech (7333)
Mergers & acquisitions (10177)
Metabolic disorders (375)
Multiple sclerosis (66)
NASH (14)
Neurodegenerative disease (57)
Neuropsychiatric disorders (12)
Neuroscience (1606)
NextGen: Class of 2025 (4186)
Non-profit (4278)
Northern California (1586)
Now hiring (30)
Obesity (183)
Opinion (169)
Ovarian cancer (59)
Pain (44)
Pancreatic cancer (50)
Parkinson's disease (101)
Partnered (15)
Patents (125)
Patient recruitment (62)
Peanut (31)
People (39000)
Pharmaceutical (28)
Pharmacy benefit managers (6)
Phase I (15773)
Phase II (20854)
Phase III (15380)
Pipeline (690)
Podcasts (25)
Policy (67)
Postmarket research (2043)
Preclinical (7537)
Press Release (65)
Prostate cancer (62)
Psychedelics (22)
Radiopharmaceuticals (184)
Rare diseases (252)
Real estate (4043)
Recruiting (41)
Regulatory (13175)
Reports (28)
Research institute (2537)
Resumes & cover letters (232)
Rett syndrome (1)
RSV (21)
Schizophrenia (53)
Series A (94)
Series B (49)
Service/supplier (10)
Sickle cell disease (40)
Southern California (1390)
Special edition (12)
Sponsored (23)
Startups (2535)
Stomach cancer (4)
Supply chain (27)
The Weekly (15)
United States (13378)
Vaccines (504)
Venture capitalists (18)
Webinars (10)
Weight loss (103)
Women's health (13)
Worklife (8)
Date
Today (115)
Last 7 days (542)
Last 30 days (2044)
Last 365 days (24589)
2025 (3975)
2024 (25052)
2023 (28960)
2022 (39039)
2021 (41582)
2020 (38259)
2019 (31888)
2018 (24100)
2017 (22433)
2016 (21986)
2015 (25802)
2014 (19281)
2013 (16689)
2012 (16707)
2011 (17503)
2010 (16176)
Location
Africa (599)
Alabama (41)
Alaska (3)
Arizona (85)
Arkansas (6)
Asia (28381)
Australia (5360)
California (3553)
Canada (1224)
China (309)
Colorado (138)
Connecticut (173)
Delaware (67)
Europe (65959)
Florida (524)
Georgia (122)
Idaho (34)
Illinois (297)
India (17)
Indiana (195)
Iowa (5)
Japan (111)
Kansas (65)
Kentucky (17)
Louisiana (3)
Maine (20)
Maryland (520)
Massachusetts (2583)
Michigan (136)
Minnesota (197)
Mississippi (1)
Missouri (44)
Montana (22)
Nebraska (15)
Nevada (26)
New Hampshire (30)
New Jersey (1062)
New Mexico (26)
New York (1043)
North Carolina (663)
North Dakota (5)
Northern California (1586)
Ohio (131)
Oklahoma (7)
Oregon (15)
Pennsylvania (720)
Puerto Rico (3)
Rhode Island (15)
South America (697)
South Carolina (6)
South Dakota (1)
Southern California (1390)
Tennessee (43)
Texas (530)
Utah (107)
Virginia (83)
Washington D.C. (44)
Washington State (366)
West Virginia (1)
Wisconsin (31)
460,625 Results for "multiple myeloma research foundation mmrf".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
The Multiple Myeloma Research Foundation (MMRF) Announces the First Patient Enrolled in its Horizon Clinical Trials Program to Accelerate the Identification of Optimal Treatment Strategies for Multiple Myeloma
December 5, 2024
·
3 min read
Business
Multiple Myeloma Research Foundation (MMRF) Presents New Data from Multiple Myeloma Research Programs at the 21st International Myeloma Society Annual Meeting
September 25, 2024
·
5 min read
Press Releases
Multiple Myeloma Research Foundation (MMRF) Announces New Publication on CoMMpass℠ Study in Nature Genetics Defining Distinct Subtypes of Multiple Myeloma and High-Risk Genetic Markers
August 19, 2024
·
4 min read
Cancer
Reframing Multiple Myeloma: From Fatal to Chronic and Even Curable
Traditionally carrying a dire prognosis, the treatment paradigm for multiple myeloma is changing, with CAR T therapies, bispecifics and more contributing to multifaceted regimens unique to each patient’s needs.
January 21, 2025
·
8 min read
·
Kate Goodwin
Pharm Country
The Multiple Myeloma Research Foundation Announces $21M Grant Program to Support Multicenter Translational Research Networks
The Multiple Myeloma Research Foundation announced the recipients of three $7 million MMRF Myeloma Accelerator Challenge Program Grants totaling $21 million.
November 2, 2023
·
5 min read
MMRF Research Programs Expand Understanding of the Biology of Multiple Myeloma and Patient-Reported Outcomes in New Data Featured at the 20th IMS Annual Meeting
The Multiple Myeloma Research Foundation (MMRF) today announced that findings from three studies based on analyses of its CoMMpass℠ and CureCloud℠ datasets
September 27, 2023
·
4 min read
Pharm Country
The Multiple Myeloma Research Foundation (MMRF) Names Stephanie Oestreich, Ph.D., MPA, as Managing Director of the Myeloma Investment Fund (MIF)
The Multiple Myeloma Research Foundation has announced the appointment of Stephanie Oestreich, Ph.D., MPA, as Managing Director of its venture philanthropy subsidiary, the Myeloma Investment Fund.
October 5, 2023
·
3 min read
Cancer
GSK Builds Case for Blenrep with Multiple Myeloma OS Data That Bests J&J’s Darzalex
GSK is carving out a niche for Blenrep in the second-line multiple myeloma setting, for which it projects multi-blockbuster potential for the antibody-drug conjugate.
November 14, 2024
·
2 min read
·
Tristan Manalac
Press Releases
Linvoseltamab Recommended for EU Approval by the CHMP to Treat Relapsed/Refractory Multiple Myeloma
March 3, 2025
·
11 min read
Press Releases
Press Release: Sarclisa approved in Japan for patients with newly diagnosed multiple myeloma
February 25, 2025
·
8 min read
1 of 46,063
Next
